Research
Adipocyte mitochondrial genes and the forkhead factor FOXC2 are decreased in type 2 diabetes patients and normalized in response to rosiglitazone
-
* Corresponding author: Joakim Håkansson Joakim@pharmasurgics.se
1 Department of Medical and Clinical Genetics, Institute of Biomedicine University of Gothenburg, Göteborg, Sweden
2 PharmaSurgics AB, Arvid Wallgrens backe 20, Göteborg, Sweden
3 The Lundberg Laboratory for Diabetes Research, Department of Molecular and Clinical Medicine, The Sahlgrenska Academy at the University of Gothenburg, Göteborg, Sweden
Diabetology & Metabolic Syndrome 2011, 3:32 doi:10.1186/1758-5996-3-32
Published: 18 November 2011Additional files
Additional file 1:
Clinical variables I. The clinical variables systolic pressure (a), diastolic pressure (b), the calculated value for HOMA-IR (c) and Hba1c (d) of the healthy controls and diabetic patients before and after treatment with rosiglitazone for 90 days. Bars represent mean and error bars SEM. * = p < 0.05, ** = p < 0.01, *** = p < 0.001.
Format: JPEG Size: 349KB Download file
Additional file 2:
Clinical variables II. The clinical variables cholesterol (a), LDL (b), HDL (c), free fatty acids (d) and triglycerides (e) of the healthy controls and diabetic patients before and after treatment with rosiglitazone for 90 days. Bars represent mean and error bars SEM. * = p < 0.05.
Format: JPEG Size: 776KB Download file
